Literature DB >> 22626818

Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.

Neil Boudville1, Anna Kemp, Philip Clayton, Wai Lim, Sunil V Badve, Carmel M Hawley, Stephen P McDonald, Kathryn J Wiggins, Kym M Bannister, Fiona G Brown, David W Johnson.   

Abstract

Peritonitis is a major complication of peritoneal dialysis, but the relationship between peritonitis and mortality among these patients is not well understood. In this case-crossover study, we included the 1316 patients who received peritoneal dialysis in Australia and New Zealand from May 2004 through December 2009 and either died on peritoneal dialysis or within 30 days of transfer to hemodialysis. Each patient served as his or her own control. The mean age was 70 years, and the mean time receiving peritoneal dialysis was 3 years. In total, there were 1446 reported episodes of peritonitis with 27% of patients having ≥ 2 episodes. Compared with the rest of the year, there were significantly increased odds of peritonitis during the 120 days before death, although the magnitude of this association was much greater during the 30 days before death. Compared with a 30-day window 6 months before death, the odds for peritonitis was six-fold higher during the 30 days immediately before death (odds ratio, 6.2; 95% confidence interval, 4.4-8.7). In conclusion, peritonitis significantly associates with mortality in peritoneal dialysis patients. The increased odds extend up to 120 days after an episode of peritonitis but the magnitude is greater during the initial 30 days.

Entities:  

Mesh:

Year:  2012        PMID: 22626818      PMCID: PMC3402287          DOI: 10.1681/ASN.2011121135

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

Review 1.  Innate and adaptive immunity in the pathogenesis of atherosclerosis.

Authors:  Göran K Hansson; Peter Libby; Uwe Schönbeck; Zhong-Qun Yan
Journal:  Circ Res       Date:  2002-08-23       Impact factor: 17.367

2.  The case-crossover design: a method for studying transient effects on the risk of acute events.

Authors:  M Maclure
Journal:  Am J Epidemiol       Date:  1991-01-15       Impact factor: 4.897

3.  Relevance of C-reactive protein levels in peritoneal dialysis patients.

Authors:  Adrian Fine
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

4.  Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study.

Authors:  Suzanne P McEvoy; Mark R Stevenson; Anne T McCartt; Mark Woodward; Claire Haworth; Peter Palamara; Rina Cercarelli
Journal:  BMJ       Date:  2005-07-12

5.  Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group.

Authors:  K J Jager; M P Merkus; F W Dekker; E W Boeschoten; J G Tijssen; P Stevens; W J Bos; R T Krediet
Journal:  Kidney Int       Date:  1999-04       Impact factor: 10.612

6.  Control sampling strategies for case-crossover studies: an assessment of relative efficiency.

Authors:  M A Mittleman; M Maclure; J M Robins
Journal:  Am J Epidemiol       Date:  1995-07-01       Impact factor: 4.897

7.  Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study.

Authors:  Michael Burke; Carmel M Hawley; Sunil V Badve; Stephen P McDonald; Fiona G Brown; Neil Boudville; Kathryn J Wiggins; Kym M Bannister; David W Johnson
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860

Review 8.  Should we use a case-crossover design?

Authors:  M Maclure; M A Mittleman
Journal:  Annu Rev Public Health       Date:  2000       Impact factor: 21.981

9.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

10.  Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis.

Authors:  Miguel Pérez Fontan; Ana Rodríguez-Carmona; Rafael García-Naveiro; Miguel Rosales; Pedro Villaverde; Francisco Valdés
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

View more
  60 in total

Review 1.  Peritoneal Dialysis-Associated Peritonitis.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-08       Impact factor: 8.237

2.  The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.

Authors:  Wen Tang; Yeoungjee Cho; Carmel M Hawley; Sunil V Badve; David W Johnson
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

3.  The NLRP3 Inflammasome Has a Critical Role in Peritoneal Dialysis-Related Peritonitis.

Authors:  Nicolas Hautem; Johann Morelle; Amadou Sow; Cyril Corbet; Olivier Feron; Eric Goffin; François Huaux; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2017-02-13       Impact factor: 10.121

4.  An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.

Authors:  Martin Wiesholzer; Petra Pichler; Gottfried Reznicek; Michaela Wimmer; Manuel Kussmann; Peter Balcke; Heinz Burgmann; Markus Zeitlinger; Wolfgang Poeppl
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients.

Authors:  Cécile Courivaud; Karine Bardonnet; Thomas Crepin; Catherine Bresson-Vautrin; Jean-Michel Rebibou; Didier Ducloux
Journal:  J Nephrol       Date:  2015-03-11       Impact factor: 3.902

6.  Changes in serum albumin concentrations during transition to dialysis and subsequent risk of peritonitis after peritoneal dialysis initiation: a retrospective cohort study.

Authors:  Kajohnsak Noppakun; Thanit Kasemset; Uraiwan Wongsawad; Chidchanok Ruengorn; Kednapa Thavorn; Manish M Sood; Surapon Nochaiwong
Journal:  J Nephrol       Date:  2020-03-04       Impact factor: 3.902

7.  Gastroscopy-related peritonitis in peritoneal dialysis patients.

Authors:  Annie-Claire Nadeau-Fredette; Joanne M Bargman
Journal:  Perit Dial Int       Date:  2014 Sep-Oct       Impact factor: 1.756

8.  The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis.

Authors:  Sarah Stevenson; Wen Tang; Yeoungjee Cho; David W Mudge; Carmel M Hawley; Sunil V Badve; David W Johnson
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

9.  32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

Authors:  Sadie van Esch; Raymond T Krediet; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Effects of a Statewide Protocol for the Management of Peritoneal Dialysis-Related Peritonitis on Microbial Profiles and Antimicrobial Susceptibilities: A Retrospective Five-Year Review.

Authors:  Amanda L McGuire; Christine F Carson; Timothy J J Inglis; Aron Chakera
Journal:  Perit Dial Int       Date:  2015-07-07       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.